In the latest development, the European Commission has asked the EMA's human medicines committee, the CHMP, to take a look at ...
The European medicines regulator said on Friday it will review safety information for Eisai and Biogen's Leqembi, nearly ...
Shares of BioArctic AB tumbled by 7% on Friday following news that the European Commission (EC) has requested further review of the company's Alzheimer's drug, lecanemab, by the Committee for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback